Sec. 204. Authorization and expansion of Rapid Drug Analysis and Research program
377 words·~2 min read·
/bill/118/s/5285/is/section-204·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Subject to the availability of appropriations, the Director of the National Institute of Standards and Technology (referred to in this section as the NIST Director ) may continue to carry out its Rapid Drug Analysis and Research program (referred to in this section as the RaDAR program ) that was in effect on the day before the date of the enactment of this Act. Subject to the availability of appropriations, the NIST Director may expand the RaDAR program, including by increasing the number of NIST personnel assigned to the program or increasing the amount expended by the program.
Not later than 3 years after the date of the enactment of this Act, the NIST Director shall ensure that the RaDAR program is carried out in coordination with local law enforcement or public health entities in at least 1 location in each of the States of the United States, the District of Columbia, and the Commonwealth of Puerto Rico. In carrying out the RaDAR program, the NIST Director, in consultation and coordination with private sector and academic laboratories and publicly funded forensic science service providers, medical examiners, toxicologists, and coroners, shall establish standards to enable laboratories to participate in the RaDAR program.
The Director may coordinate accreditation of competent laboratories as being in compliance with the standards established pursuant to paragraph (1). In carrying out the RaDAR program, the NIST Director shall coordinate, consult, or collaborate with— private sector and academic laboratories that may be eligible for accreditation under paragraph (2); and publicly funded forensic science service providers, medical examiners, toxicologists, and coroners. In carrying out the program authorized by subsection (a), the NIST Director may enter into such agreements with laboratories accredited pursuant to paragraph
(2)as the Director considers appropriate. In this subsection, the term appropriate congressional committees means— the Committee on Commerce, Science, and Transportation of the Senate ; and the Committee on Science, Space, and Technology of the House of Representatives . Not later than 18 months after the date of the enactment of this Act, the NIST Director shall submit a report to the appropriate congressional committees that describes— the actions taken by the NIST Director to expand the RaDAR program; and the NIST Director's plans for further expansion of the RaDAR program.